Literature DB >> 7733959

The N-terminal half of dystrophin is protected from proteolysis in situ.

S Hori1, S Ohtani, T M Nguyen, G E Morris.   

Abstract

Using a panel of "exon-specific" monoclonal antibodies, we have examined the products of degradation of dystrophin by endogenous proteases in post-mortem human muscle. Four main sites of dystrophin digestion were identified, all of them in the C-terminal half of the molecule. Two of them correspond to "hinges" in the central rod region and a third in the C-terminal domain follows the dystroglycan binding site. The results support the Koenig and Kunkel model for the tertiary structure of dystrophin (J. Biol. Chem. 265 (1990) 4560-4566), but suggest that much of the N-terminal half of dystrophin is protected from proteolysis, possibly by interaction with the sub-sarcolemmal cytoskeleton. Although the results seem inconsistent with an anti-parallel dimer model of dystrophin in which hinge 2 and hinge 3 are close together, possible ways of reconciling them with such a model are also considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733959     DOI: 10.1006/bbrc.1995.1605

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury.

Authors:  Richard M Lovering; Patrick G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

Review 2.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

3.  Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.

Authors:  K Natalie Randles; Le Thanh Lam; Caroline A Sewry; Megan Puckelwartz; Denis Furling; Manfred Wehnert; Elizabeth M McNally; Glenn E Morris
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

4.  Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype.

Authors:  K Corrado; J A Rafael; P L Mills; N M Cole; J A Faulkner; K Wang; J S Chamberlain
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

5.  A new model for the interaction of dystrophin with F-actin.

Authors:  I N Rybakova; K J Amann; J M Ervasti
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.